Compound information
- Natural Products
- ZC2802646
- Molecular Formula
- C34H41N3O6
- Molecular Weight
- 587.299536032 g/mol
- Structure
-
- IUPAC Name
- [(3S)-7-amino-3-[[(2S)-2-(benzyloxycarbonylamino)-3-phenyl-propanoyl]amino]-2-oxo-heptyl] 2,4,6-trimethylbenzoate
- InChI
- InChI=1S/C34H41N3O6/c1-23-18-24(2)31(25(3)19-23)33(40)42-22-30(38)28(16-10-11-17-35)36-32(39)29(20-26-12-6-4-7-13-26)37-34(41)43-21-27-14-8-5-9-15-27/h4-9,12-15,18-19,28-29H,10-11,16-17,20-22,35H2,1-3H3,(H,36,39)(H,37,41)/t28-,29-/m0/s1
- InChI Key
- YSVZQBHVVBVWKO-VMPREFPWSA-N
- SMILES
- Cc1cc(C)c(C(=O)OCC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccccc2)NC(=O)OCc2ccccc2)c(C)c1
- Source
- ZINC000003918141
Warheads
- Carbonyl
-
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 43 | Ring Count | 3 |
Heteroatom Count | 9 | Rotatable Bond Count | 15 |
Hydrogen Bond Acceptor Count | 7 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 136.82 Å2 | LogP | 4.829 |
LogS | -4.693 | LogD | 4.384 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.996 | Pgp substrate | 0.403 |
HIA | 0.928 | F20 % | 0.876 |
F30 % | 0.002 | Caco-2 | -5.05 |
MDCK | -5.095 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.003 | PPB | 98.9 |
VD | 0.557 | Fu | 1.612 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.058 | CYP1A2 substrate | 0.797 |
CYP2A6 substrate | 0.462 | CYP2B6 substrate | 0.697 |
CYP2C19 inhibitor | 0.843 | CYP2C19 substrate | 0.974 |
CYP2C8 substrate | 0.87 | CYP2C9 inhibitor | 0.21 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.313 |
CYP2D6 substrate | 0.827 | CYP2E1 substrate | 0.563 |
CYP3A4 inhibitor | 0.929 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.827 | CL | 5.61 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.025 | Hepatotoxicity | 0.731 |
Mutagenicity | 0.057 | Rat Oral Acute Toxicity | 0.427 |
FDAMDD | 0.944 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.004 | Eye Corrosion | 0.01 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.049 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.025 | IGC50 | 5.014 |
LC50FM | 4.946 | LC50DM | 5.654 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.227 | NR-AR-LBD | 0.413 |
NR-AhR | 0.005 | NR-Aromatase | 0.593 |
NR-ER | 0.443 | NR-ER-LBD | 0.455 |
NR-PPAR-gamma | 0.496 | SR-ARE | 0.629 |
SR-ATAD5 | 0.661 | SR-HSE | 0.404 |
SR-MMP | 0.468 | SR-p53 | 0.12 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.